AlbionVC
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
The evidence associates AlbionVC with Scripta Therapeutics, a TechBio company developing biology-first disease-modifying drug discovery using single-cell solutions, making it relevant capital for a computational single-cell drug-discovery platform.